2022 Annual Meeting | C7 - Neuroendocrine Update: Nuts and Bolts of What You Need to Know
Program Materials Program Evaluations
07:00 AM - 07:05 AM PDT | Introduction |
Introduction
Alison M. Pack, MD, FAAN |
07:00 AM - 09:00 AM PDT | Speaker |
walk in slides
Alison M. Pack, MD, FAAN |
07:05 AM - 07:30 AM PDT | Speaker |
Neuroendocrine Axes: Hypothalamus, Pituitary, and Beyond
Karen K. Miller, MD |
07:30 AM - 07:55 AM PDT | Speaker |
Epilepsy, Antiepileptic Drugs, and Neuroendocrine Effects
Alison M. Pack, MD, FAAN |
07:55 AM - 08:20 AM PDT | Speaker |
Neuroendocrine Aspects of Cognitive Aging and Dementia
Victor W. Henderson, MD, FAAN |
08:20 AM - 08:45 AM PDT | Speaker |
Neurocritical Care and Neuroendocrinology: An Overview
Torrey B. Birch, MD, FAAN |
08:45 AM - 09:00 AM PDT | Q&A |
Questions and Answers
Alison M. Pack, MD, FAAN, Victor W. Henderson, MD, FAAN, Torrey B. Birch, MD, FAAN, Karen K. Miller, MD |
Victor W. Henderson, MD, FAAN | Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities. |
Alison M. Pack, MD, FAAN | An immediate family member of Dr. Pack has received personal compensation for serving as an employee of REGENEXBIO. The institution of Dr. Pack has received research support from National Institutes of Health. Dr. Pack has received publishing royalties from a publication relating to health care. |
Torrey B. Birch, MD, FAAN | Dr. Birch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon Biosciences. |
Karen K. Miller, MD | Dr. Klahr Miller has stock in Amgen. Dr. Klahr Miller has stock in Bristol-Myers Squibb . Dr. Klahr Miller has stock in GE. Dr. Klahr Miller has stock in Boston Scientific. Dr. Klahr Miller has stock in Becton Dickinson. An immediate family member of Dr. Klahr Miller has stock in Bristol-Myers Squibb . An immediate family member of Dr. Klahr Miller has stock in GE. An immediate family member of Dr. Klahr Miller has stock in Boston Scientific. An immediate family member of Dr. Klahr Miller has stock in Bristol-Myers Squibb . The institution of Dr. Klahr Miller has received research support from Amgen. The institution of Dr. Klahr Miller has received research support from Pfizer. Dr. Klahr Miller has received publishing royalties from a publication relating to health care. |